1-9 of 9
Aaron P. Rapoport
Close
Sort by
Journal Articles

Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7

Clinical Trials & Observations
Armin Ghobadi, Javier Munoz, Jason R. Westin, Frederick L. Locke, David B. Miklos, Aaron P. Rapoport, Miguel-Angel Perales, Patrick M. Reagan, Joseph McGuirk, Caron A. Jacobson, Marie José Kersten, Irit Avivi, Andrew Peng, Marco Schupp, Christina To, Olalekan O. Oluwole
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2982–2990.
https://doi.org/10.1182/bloodadvances.2023011532
Published: 2024
Includes: Supplemental data
Journal Articles

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

Clinical Trials & Observations
Michael D. Jain, Miriam T. Jacobs, Feng Gao, Loretta J. Nastoupil, Jay Y. Spiegel, Yi Lin, Saurabh Dahiya, Matthew Lunning, Lazaros Lekakis, Patrick Reagan, Olalekan Oluwole, Joseph McGuirk, Abhinav Deol, Alison R. Sehgal, Andre Goy, Brian T. Hill, Charalambos Andreadis, Javier Munoz, Julio C Chavez, N. Nora Bennani, Aaron P. Rapoport, Julie M. Vose, David Miklos, Sattva S. Neelapu, Frederick L. Locke, Armin Ghobadi
Journal: Blood Advances
Blood Adv (2024) 8 (4): 1042–1050.
https://doi.org/10.1182/bloodadvances.2023011489
Published: 2024
Includes: Supplemental data
Journal Articles

Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myeloma

Clinical Trials & Observations
Taiga Nishihori, James E. Hoffman, Anne Huff, Gurpreet S. Kapoor, Ioanna Eleftheriadou, Stefan Zajic, Alisa Urbano, Sunil Suchindran, Michael Chisamore, Jimson W. D’Souza, Thomas Faitg, Aaron P. Rapoport
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1168–1177.
https://doi.org/10.1182/bloodadvances.2022008460
Published: 2023
Includes: Supplemental data
Journal Articles

Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy

Saurabh Dahiya, Tim Luetkens, Forat Lutfi, Stephanie Avila, Thierry Iraguha, Philip Margiotta, Kim G. Hankey, Patricia Lesho, Jennie Y. Law, Seung T. Lee, John Baddley, Mehmet Kocoglu, Jean A. Yared, Nancy M. Hardy, Aaron P. Rapoport, Djordje Atanackovic
Journal: Blood Advances
Blood Adv (2022) 6 (2): 686–689.
https://doi.org/10.1182/bloodadvances.2021006112
Published: 2022
Includes: Supplemental data
Journal Articles

Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy

Clinical Trials & Observations
Khushali S. Jhaveri, Ilana Schlam, Noa G. Holtzman, Monica Peravali, Perry K. Richardson, Saurabh Dahiya, Vera Malkovska, Aaron P. Rapoport
Journal: Blood Advances
Blood Adv (2020) 4 (23): 6019–6022.
https://doi.org/10.1182/bloodadvances.2020003176
Published: 2020
Journal Articles

Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19

Clinical Trials & Observations
Tim Luetkens, Ryan Metcalf, Vicente Planelles, Yue Zheng, Erin T. Larragoite, Emily S. Spivak, Adam M. Spivak, Mary Steinbach, Robert C. Blaylock, Stephanie V. Avila, Kim G. Hankey, Thomas B. Martins, Patricia R. Slev, Heather D. Mannuel, Mohammad Sajadi, Aaron P. Rapoport, Djordje Atanackovic
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4864–4868.
https://doi.org/10.1182/bloodadvances.2020002595
Published: 2020
Journal Articles

T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma

Alfred L. Garfall, Ehren K. Dancy, Adam D. Cohen, Wei-Ting Hwang, Joseph A. Fraietta, Megan M. Davis, Bruce L. Levine, Don L. Siegel, Edward A. Stadtmauer, Dan T. Vogl, Adam Waxman, Aaron P. Rapoport, Michael C. Milone, Carl H. June, J. Joseph Melenhorst
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2812–2815.
https://doi.org/10.1182/bloodadvances.2019000600
Published: 2019
Includes: Supplemental data
Journal Articles

Long‐term safety and activity of NY-ESO‐1 SPEAR T cells after autologous stem cell transplant for myeloma

Clinical Trials & Observations
Edward A. Stadtmauer, Thomas H. Faitg, Daniel E. Lowther, Ashraf Z. Badros, Karen Chagin, Karen Dengel, Malini Iyengar, Luca Melchiori, Jean-Marc Navenot, Elliot Norry, Trupti Trivedi, Ruoxi Wang, Gwendolyn K. Binder, Rafael Amado, Aaron P. Rapoport
Journal: Blood Advances
Blood Adv (2019) 3 (13): 2022–2034.
https://doi.org/10.1182/bloodadvances.2019000194
Published: 2019
Includes: Supplemental data
Journal Articles

Long-term remissions after stopping pembrolizumab for relapsed or refractory multiple myeloma

Clinical Trials & Observations
Ashraf Z. Badros, Ning Ma, Aaron P. Rapoport, Emily Lederer, Alexander M. Lesokhin
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1658–1660.
https://doi.org/10.1182/bloodadvances.2019000191
Published: 2019